kidney issues with tirzepatide linked to lower risk for death, adverse CV and outcomes vs. GLP-1s Kidney Parameters with Tirzepatide in

Developed in the 1980s by researchers at the University of Arizona, it was originally investigated as part of efforts to reduce UV-related skin damage

To ensure comparability between groups, inverse probability of treatment weighting was applied to balance baseline characteristics

As part of the Renew You program, your first dose can be administered by a clinical team member at Renew

This article is part of Solutionaries, our continuing commitment to solutions journalism, highlighting the creative people in communities working to make the world a better place, one solution at a time

A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA adverse event reporting system (FAERS) database

2023, doi: 10.1056/NEJMoa2301972